BoonchaiW, CharoenpipatsinN, WinayanuwattikunW, et al.Assessment of the quality of life (QoL) of patients with dermatitis and the impact of patch testing on QoL: A study of 519 patients diagnosed with dermatitis. Contact Dermatitis. 2020;83(3):182–188; doi: 10.1111/cod.13535
2.
YakupuA, AimaierR, YuanB, et al.The burden of skin and subcutaneous diseases: Findings from the global burden of disease study 2019. Front Public Health. 2023;11(11):1145513; doi: 10.3389/fpubh.2023.1145513
3.
QianMF, LiS, HonariG, et al.Sociodemographic disparities in patch testing for commercially insured patients with dermatitis: A retrospective analysis of administrative claims data. J Am Acad Dermatol. 2022;87(6):1411–1413; doi: 10.1016/j.jaad.2022.08.041
4.
WoodruffCM, KaurG, BottoN. Racial disparities in access to patch testing: A cross-sectional study. Br J Dermatol. 2022;187(5):784–785; doi: 10.1111/bjd.21680